NCT00031031View on ClinicalTrials.gov

Kanglaite Injection Phase I Study

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

June 30, 2001

Study Completion Date

November 30, 2002

Conditions
Solid Tumors Refractory To Standard TherapyNeoplasms
Interventions
DRUG

Kanglaite Injection (KLT)

Trial Locations (1)

84112

Huntsman Cancer Institue, Salt Lake City

All Listed Sponsors
lead

KangLaiTe USA

INDUSTRY

NCT00031031 - Kanglaite Injection Phase I Study | Biotech Hunter | Biotech Hunter